Selective Laser Trabeculoplasty

In this interview, Dr. Mark Latina, inventor of selective laser trabeculoplasty (SLT), explains how the technology and approach were conceived, the presumed mechanism of action, and which glaucoma patients are best candidates for the treatment. The therapeutic benefits of SLT in comparison with other treatment options include cost savings, efficacy, safety, and repeatability. It has the added benefit of reducing the burden of medical treatment and thereby mitigating compliance problems common among glaucoma patients.